These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 19451909)

  • 21. Counterfeit drugs: implications for health.
    ten Ham M
    Adverse Drug React Toxicol Rev; 1992; 11(1):59-65. PubMed ID: 1606284
    [No Abstract]   [Full Text] [Related]  

  • 22. Tackling corruption in the pharmaceutical systems worldwide with courage and conviction.
    Cohen JC; Mrazek M; Hawkins L
    Clin Pharmacol Ther; 2007 Mar; 81(3):445-9. PubMed ID: 17251983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drugs, drugs--who has the drugs?
    Blair J
    J Healthc Prot Manage; 2012; 28(1):28-32. PubMed ID: 22423518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Counterfeit pharmaceutical products.
    World Health Forum; 1998; 19(2):213-4. PubMed ID: 9652226
    [No Abstract]   [Full Text] [Related]  

  • 25. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
    Nsimba SE
    East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Counterfeit and fake drugs: medications that kill].
    Ambroise-Thomas P
    Med Trop (Mars); 2010 Jun; 70(3):213-4. PubMed ID: 20734583
    [No Abstract]   [Full Text] [Related]  

  • 27. Protecting public health requires new tobacco product regulation, says WHO.
    J Adv Nurs; 2001 Nov; 36(3):329-30. PubMed ID: 11699513
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug and alcohol policy at the global level.
    Anderson P
    Drug Alcohol Rev; 2006 Nov; 25(6):485-7. PubMed ID: 17132568
    [No Abstract]   [Full Text] [Related]  

  • 29. Counterfeit drug demand: perceptions of policy makers and community pharmacists in Sudan.
    Alfadl AA; Hassali MA; Ibrahim MI
    Res Social Adm Pharm; 2013; 9(3):302-10. PubMed ID: 22835708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding and fighting the medicine counterfeit market.
    Dégardin K; Roggo Y; Margot P
    J Pharm Biomed Anal; 2014 Jan; 87():167-75. PubMed ID: 23384475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substandard and counterfeit medicines.
    Rassool GH
    J Adv Nurs; 2004 May; 46(3):338-9. PubMed ID: 15119344
    [No Abstract]   [Full Text] [Related]  

  • 32. Bad medicine in the market.
    Roger B; Boateng K
    World Hosp Health Serv; 2007; 43(3):17-21. PubMed ID: 18269104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safeguarding against substandard/counterfeit drugs: mitigating a macroeconomic pandemic.
    Wertheimer AI; Norris J
    Res Social Adm Pharm; 2009 Mar; 5(1):4-16. PubMed ID: 19285285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Counterfeit and substandard drugs in India may be smaller problem than claimed, say government findings.
    Travasso C
    BMJ; 2014 Jan; 348():g60. PubMed ID: 25489932
    [No Abstract]   [Full Text] [Related]  

  • 35. International control of alcohol: alternative paths forward.
    Room R
    Drug Alcohol Rev; 2006 Nov; 25(6):581-95. PubMed ID: 17132575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rethinking global health challenges: towards a 'global compact' for reducing the burden of chronic disease.
    Magnusson RS
    Public Health; 2009 Mar; 123(3):265-74. PubMed ID: 19278695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Counterfeit medicines: report of a cross-sectional retrospective study in Iran.
    Hosseini SA; Darbooy Sh; Tehrani Banihashemi SA; Naseri SM; Dinarvand R
    Public Health; 2011 Mar; 125(3):165-71. PubMed ID: 21397286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Food safety.
    Elmi M
    East Mediterr Health J; 2008; 14 Suppl():S143-9. PubMed ID: 19205614
    [No Abstract]   [Full Text] [Related]  

  • 39. Canadian policy makers' views on pharmaceutical reimbursement contracts involving confidential discounts from drug manufacturers.
    Morgan SG; Thomson PA; Daw JR; Friesen MK
    Health Policy; 2013 Oct; 112(3):248-54. PubMed ID: 23809914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Counterfeiting and piracy of pharmaceuticals.
    Grackin A
    IEEE Eng Med Biol Mag; 2008; 27(6):66-9. PubMed ID: 19004698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.